ETH Zurich
-
Business & Markets · Enterprise
AI-designed TNIK Inhibitors Could Treat a Range of Aging-Related Diseases, From Fibrosis to Alzheimer’s.
Insider Brief Researchers reveal the broad potential of TNIK as a therapeutic target for some of the most pervasive aging-related diseases — including fibrosis, cancer, obesity, and Alzheimer’s — in a new paper. The… -
Technology & Infrastructure · Models & LLMs 9 Best Universities For Artificial Intelligence Reserach in 2025
-
Business & Markets · Startups mimic Raises $2.5 Million– Joins The Race to Develop The First AI-driven Collaborative Robot
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.